Market Watch Highlights: 10x Genomics Inc (TXG) Ends on an Upturn Note at 9.34

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

As of close of business last night, 10x Genomics Inc’s stock clocked out at $9.34, up 2.52% from its previous closing price of $9.11. In other words, the price has increased by $2.52 from its previous closing price. On the day, 3.49 million shares were traded.

Ratios:

To gain a deeper understanding of TXG’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.73 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.71. For the most recent quarter (mrq), Quick Ratio is recorded 4.68 and its Current Ratio is at 5.37. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on February 13, 2025, Downgraded its rating to Market Perform and sets its target price to $12 from $25 previously.

On September 03, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $35.

Jefferies Upgraded its Hold to Buy on July 22, 2024, while the target price for the stock was maintained at $24.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 22 ’25 when Saxonov Serge sold 9,343 shares for $8.30 per share. The transaction valued at 77,540 led to the insider holds 1,083,625 shares of the business.

Hindson Benjamin J. sold 7,485 shares of TXG for $62,120 on May 22 ’25. The insider now owns 448,374 shares after completing the transaction at $8.30 per share. On May 22 ’25, another insider, Taich Adam, who serves as the Chief Financial Officer of the company, sold 4,044 shares for $8.30 each. As a result, the insider received 33,562 and left with 331,588 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 1.87 while its Price-to-Book (P/B) ratio in mrq is 1.63.

Stock Price History:

Over the past 52 weeks, TXG has reached a high of $24.76, while it has fallen to a 52-week low of $6.78. The 50-Day Moving Average of the stock is 8.83%, while the 200-Day Moving Average is calculated to be -34.32%.

Shares Statistics:

A total of 109.08M shares are outstanding, with a floating share count of 103.46M. Insiders hold about 17.13% of the company’s shares, while institutions hold 90.02% stake in the company.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.